Dr Tim Boyle joined ARCS Australia as CEO in November 2023, previously serving in senior leadership and executive roles at ANSTO. A recognized leader in research translation and IP commercialisation, he has over two decades of experience in technology licensing and developing science based ventures. Previously Tim also served as Executive Chair of ATTP, and is a life member and former non-executive director of Knowledge Commercialisation Australasia. Tim also holds appointments as an Adjunct Professor at Swinburne University of Technology, and Global Expert Faculty at Singularity University.

Karen is a corporate and privacy lawyer with over 15 years of experience. She is a qualified lawyer in Australia, New York and England and Wales and has been a legal business partner for medical devices, pharmaceutical, and financial services clients in Australia and Hong Kong. Karen has advised on AI, ethics and governance framework development, training and rollout and been the legal lead on machine learning projects in predictive medicine and clinical studies. She has led privacy reform and regulatory change projects from a legal perspective for ASX-listed and international organisations. Her experience includes advising the board on directors’ duties and advising senior management on regulatory investigations, the adoption of emerging technology and digital platforms, management of business assets including data, and data breach preparation and responses. In 2023, Karen was a speaker on AI at the Australasian Institute of Digital Health’s AI+ Care conference in Brisbane and co-led a Generative AI Masterclass at the Association of Corporate Counsel’s National Conference in Canberra. She is currently the Chair of the Association of Corporate Counsel Australia’s Legal Technology and Innovation Committee and a member of the Australian Institute of Digital Health NSW Branch committee.

Andrew’s Career in Healthcare spans 35 years. In his current role Andrew has responsibility for Healthcare Policy, supporting AWS public policy teams across the APAC region Previously Andrew led the Health Economics, Market Access, Policy and Government and Stakeholder Relations functions for Medtronic in Australia and New Zealand, in addition to coordinating Government Affairs for the APAC region. Before that Andrew had a variety of roles within Healthcare organisations across business and functional leadership. In addition to his Medtech experience, Andrew started his career as a Registered Nurse and has worked in the Pharmaceutical Industry as well as a brief stint in the Hospitality Industry. He holds an MBA from the University of New England and a BA in Media from Griffith University. He is an ARCS Australia Board Member and is Chair of the MTAA Digital Health Advisory Group and Co-Chair of the US-ASEAN Business Council Digital Health Committee.

Michelle is an award-winning health technology entrepreneur with a particular interest in artificial intelligence, clinical trials and ethics. Recently commencing as the inaugural CEO of Cerulea Clinical Trials, a not-for-profit spin out from the Centre for Eye Research Australia, Michelle’s current focus is on building a world-leading ophthalmic clinical trials company specialising in gene therapy trials, medical devices and applying emerging AI-enabled efficiency solutions that will improve outcomes and reduce costs. Commencing in allied health, Michelle’s career spans clinical and administrative roles in public and private healthcare, commercial and executive roles within biotech, pharmaceutical, and medical organisations, as well as and leading a biotech peak-body. Michelle moved from the corporate world to found her first startup in 2014, successfully selling that business three years later, going on to found AI health tech company Opyl Ltd in 2019 (ASX:OPL). During COVID, Michelle designed and directed the successful build of Opyl’s two technology platforms; Opin, to accelerate recruitment of patients to trials, and TrialKey, an AI tool that predicts the outcomes of trials and optimises trial designs so they are more likely to succeed. The appropriate application of AI in healthcare and the role of ethics and digital leadership in technology development is a key issue that Michelle is renowned for as a key opinion leader and advocate. Michelle is an experienced non-executive director on several boards and is co-founder of not-for-profit advocacy organisation, Women in STEMM Australia. Michelle is a Victorian Honour Roll for Women inductee, Victorian Telstra Businesswoman and Entrepreneur of the Year, and a winner of Westpac’s 200 Businesses of Tomorrow. Michelle has an undergraduate degree in applied science, postgraduate qualifications in business and product management, a Global Executive MBA, is a graduate of the Institute for Company Directors and a Fellow of the Australian Institute for Management. Michelle hates cricket and always has.

Farah Magrabi is a Professor of Biomedical and Health Informatics at the Australian Institute of Health Innovation, Macquarie University. She has a background in Electrical and Biomedical Engineering, and has worked as a health services researcher for 20 years. At the Australian Institute of Health Innovation, she leads research to improve the clinical safety and effectiveness of digital health and AI technologies for clinicians and consumers. Professor Magrabi is co-chair of the Australian AI Alliance’s Working Group on safety, quality and ethics; and an advisor to the Australian Digital Health Agency.

Fiona McCormack is the Director of the Devices Emerging Technology Section within the Medical Devices Surveillance Branch at the TGA. Fi’s background is a Medical Scientist, and she has worked in various technical roles within the TGA for the past 18 years. Fi has extensive regulatory and technical knowledge across multiple areas, including in vitro diagnostics (IVDs) and medical devices, software and AI-based products, quality management systems, auditing and the certification of device manufacturers.